+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Fluorescein angiographic studies on retinopathy of prematurity



Fluorescein angiographic studies on retinopathy of prematurity



Nippon Ganka Gakkai Zasshi 80(10): 1204-1215




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 026643444

Download citation: RISBibTeXText

PMID: 1034419


Related references

Retinopathy of prematurity fluorescein angiographic and histo pathologic studies on infants receiving high and low doses of vitamin e. Pediatric Research 15(4 Part 2): 673, 1981

Regressive and progressive cases of retinopathy of prematurity. Fluorescein angiographic observations. Nippon Ganka Gakkai Zasshi 81(8): 950-957, 1977

Atlas of fluorescein angiographic findings in eyes undergoing laser for retinopathy of prematurity. Ophthalmology 118(1): 168-175, 2011

Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings. Ophthalmology 121(11): 2212-2219, 2014

Aggressive Posterior Retinopathy of Prematurity Treated with Intravitreal Bevacizumab: Late Period Fluorescein Angiographic Findings. Graefe's Archive for Clinical and Experimental Ophthalmology 257(6): 1141-1146, 2019

Follow-up to Age 4 Years of Treatment of Type 1 Retinopathy of Prematurity Intravitreal Bevacizumab Injection versus Laser: Fluorescein Angiographic Findings. Ophthalmology, 2017

RETINAL VASCULAR DEVELOPMENT WITH 0.312 MG INTRAVITREAL BEVACIZUMAB TO TREAT SEVERE POSTERIOR RETINOPATHY OF PREMATURITY: A Longitudinal Fluorescein Angiographic Study. Retina 37(1): 97, 2017

Comparison of fluorescein angiographic findings in type 1 and type 2 retinopathy of prematurity with intravitreal bevacizumab monotherapy and spontaneous regression. International Ophthalmology 39(10): 2267-2274, 2019

Fluorescein angiographic observations of peripheral retinal vessel growth in infants after intravitreal injection of bevacizumab as sole therapy for zone I and posterior zone II retinopathy of prematurity. British Journal of Ophthalmology 98(4): 507-512, 2014

Fluorescein angiographic studies on retinal changes in hypertension. 2. Fluorescein angiographic findings of the fundus hypertonicus. Nippon Ganka Gakkai Zasshi 75(10): 2120-2126, 1971

Retinopathy of prematurity outcome in infants with prethreshold retinopathy of prematurity and oxygen saturation >94% in room air: the high oxygen percentage in retinopathy of prematurity study. Pediatrics 110(3): 540-544, 2002

Fundus fluorescein angiography in retinopathy of prematurity. Journal of Pediatric Ophthalmology and Strabismus 43(2): 78, 2006

Fluorescein staining of the vitreous during vitrectomy for retinopathy of prematurity. Retina 31(8): 1717-1719, 2011

Early retinopathy of prematurity findings identified with fluorescein angiography. Graefe's Archive for Clinical and Experimental Ophthalmology 251(9): 2093-2097, 2013

Influence of Fluorescein Angiography on the Diagnosis and Management of Retinopathy of Prematurity. Ophthalmology 122(8): 1601-1608, 2015